In Situ Spatiotemporal Tracking of Endogenous Proteins: Allosteric Biosensor Advances

Study Background and Research Question

Elucidating the roles of proteins within their native cellular contexts is essential for understanding molecular mechanisms underlying health and disease. Traditional imaging strategies, such as immunofluorescence, genetically encoded fluorescent tags, or chemical labeling, often require overexpression or genetic modification of the protein of interest (POI). While these methods have enabled significant advances, they risk introducing artifacts that can misrepresent true protein behavior, folding, localization, or function. Direct visualization of unmodified, endogenous proteins in living cells remains a major technological challenge, largely due to limitations in specificity, background noise, and the need for perturbative labeling strategies. The study by Xie et al. (DOI:10.1016/j.bios.2026.118829) addresses these constraints by developing a biosensor system capable of tracking native protein dynamics in situ without genetic or chemical modification of the POI itself.

Key Innovation from the Reference Study

The central innovation described in the reference paper is the creation of an allosteric, genetically encoded biosensor—termed "Step"—for tracking endogenous POI dynamics in living cells. This biosensor system uniquely combines a POI-recognizing RNA aptamer with a dual-locked, fluorogenic RNA aptamer module. The design leverages allosteric switching: a single POI–aptamer interaction triggers unlocking of two caged fluorogenic aptamers, restoring their active conformations and producing a robust, low-background fluorescent readout. This enables real-time, high-fidelity imaging of endogenous protein localization and abundance without requiring exogenous tags or protein modification, thus preserving the physiological context of the studied proteins. The modular, plug-and-play architecture of the Step biosensor also facilitates adaptation to different target proteins and cellular environments.

Methods and Experimental Design Insights

Xie et al. implemented a circularized biosensor RNA (circStep) expressed in living cells. The system comprises two main components:

• Protein-recognizing aptamer: Engineered to bind specifically to the endogenous POI with high affinity and minimal off-target interactions.
• Dual-locked fluorogenic aptamer module (M18): Caged by design, the fluorogenic aptamers remain inactive until the POI–aptamer binding event triggers a conformational switch, simultaneously unmasking both modules and enabling strong fluorescence emission.

This architecture ensures a sharp on/off signal, minimizing background fluorescence and off-target binding. The system was delivered into living cells using methods compatible with typical molecular biology workflows. Fluorescence microscopy and high-throughput imaging platforms were employed to monitor POI localization and abundance changes with high spatial and temporal resolution.

Protocol Parameters

• Biosensor RNA expression: Delivered via standard transfection or microinjection protocols; expression levels optimized to avoid overloading cellular RNA machinery.
• Fluorogenic aptamer activation: Fluorescence signal is contingent upon specific POI–aptamer interaction; fluorescence measured in live-cell imaging setups.
• Controls: Use of aptamer mutants and POI knockdown/knockout cell lines to confirm specificity and minimize false positives.
• Imaging parameters: Real-time tracking performed at temporal resolutions appropriate for monitoring protein translocation events (e.g., nucleocytoplasmic transport).

Although the study does not focus on in vitro transcription RNA labeling, the biosensor's reliance on synthetic RNA modules highlights the importance of high-quality RNA synthesis and labeling for similar experimental designs.

Core Findings and Why They Matter

By leveraging an allosteric switch within a genetically encoded RNA biosensor, the study achieved several meaningful advances:

• High specificity and low background: The dual-locked aptamer design ensures fluorescent activation only upon bona fide POI binding, sharply reducing the risk of spurious signals.
• Real-time tracking of endogenous proteins: The biosensor enables dynamic observation of native protein localization and abundance fluctuations, including direct visualization of nucleocytoplasmic transport and relocalization events.
• Non-perturbative monitoring: Crucially, the approach does not require genetic tagging or chemical modification of the POI, thus preserving native protein function and cellular context.
• High-throughput compatibility: The robust, fluorescence-based signal allows for scalable imaging-based screening, such as the evaluation of drug effects on protein relocalization.

This methodological advance expands the toolkit for studying protein function in living cells, particularly for targets where traditional tagging or overexpression strategies are problematic or artifact-prone. The platform is especially promising for drug discovery applications that require high-content, physiologically relevant screening of protein dynamics.

Comparison with Existing Internal Articles

While the reference study focuses on live-cell imaging of endogenous proteins using an allosteric RNA aptamer biosensor, several internal articles discuss complementary RNA labeling technologies and their impact on molecular biology research:

• The article "Biotin-16-UTP: Advancing RNA-Protein Interaction Research" emphasizes the value of biotin-labeled uridine triphosphate analogs for in vitro transcription and downstream RNA-protein interaction studies. Biotin-16-UTP enables sensitive RNA detection, purification, and interactome mapping, which are foundational for preparing high-purity RNA aptamers or biosensor modules for applications such as those in the reference study.
• "Biotin-16-UTP: Precision Biotin-Labeled Uridine Triphosphate for RNA Assays" provides practical guidance for researchers seeking stepwise protocols and troubleshooting strategies for biotin-labeled RNA synthesis, supporting robust workflows for RNA detection and purification.

Although the allosteric biosensor system in the reference study does not directly employ biotinylation, the utilization of synthetic or in vitro transcribed RNA modules in advanced biosensor design highlights the broader importance of high-quality, labeled RNA reagents. Biotin-16-UTP, as described in these internal articles, remains an essential tool for molecular workflows requiring RNA labeling, such as pull-downs, interaction mapping, or affinity-based purification—key steps in validating RNA-protein interactions or preparing biosensor components.

Limitations and Transferability

The Step biosensor system, while representing a significant advance, has certain limitations:

• Target specificity: The design requires the development of high-affinity aptamers for each POI, which may be challenging for proteins lacking well-characterized RNA-binding surfaces.
• RNA stability: Expression and maintenance of biosensor RNA in living cells can be affected by endogenous nucleases and RNA turnover pathways.
• Generalizability: While the modular system is adaptable, each new POI requires custom aptamer engineering and validation.
• Imaging constraints: The system's utility depends on access to appropriate fluorescence imaging platforms and may be limited by cell type or experimental throughput.

Despite these considerations, the platform is broadly transferable to other live-cell studies of endogenous proteins—particularly where non-perturbative, real-time visualization is required.

Research Support Resources

For researchers aiming to synthesize or label RNA modules for biosensor construction, or for advanced RNA-protein interaction studies, the use of biotin-labeled uridine triphosphate reagents such as Biotin-16-UTP (SKU B8154) is recommended. This reagent enables efficient incorporation of biotin into RNA during in vitro transcription, supporting sensitive detection, purification, and interactome analysis workflows in line with the needs of biosensor development and RNA-protein interaction assays. For further practical protocols and comparative guidance, see internal articles such as "Biotin-16-UTP: Precision Biotin-Labeled RNA Synthesis for..." and "Biotin-16-UTP: Practical Guide for RNA Labeling Workflows." While the core innovation of the Step biosensor lies in its genetically encoded, non-biotin-based detection, high-purity RNA labeling strategies remain integral to the development and validation of next-generation biosensors for live-cell applications.